Adaptimmune Therapeutics PLC
NASDAQ:ADAP
Income Statement
Earnings Waterfall
Adaptimmune Therapeutics PLC
Revenue
|
60.3m
USD
|
Operating Expenses
|
-191m
USD
|
Operating Income
|
-130.7m
USD
|
Other Expenses
|
16.8m
USD
|
Net Income
|
-113.9m
USD
|
Income Statement
Adaptimmune Therapeutics PLC
Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||||||||||||
Revenue |
14
N/A
|
14
0%
|
17
+23%
|
42
+143%
|
38
-10%
|
43
+14%
|
49
+13%
|
62
+28%
|
60
-4%
|
51
-14%
|
42
-17%
|
2
-96%
|
1
-40%
|
2
+69%
|
2
+18%
|
3
+43%
|
4
+25%
|
4
-9%
|
6
+72%
|
6
+0%
|
6
-1%
|
9
+51%
|
12
+26%
|
18
+49%
|
27
+55%
|
71
+162%
|
71
-1%
|
71
+0%
|
60
-15%
|
|
Operating Income | ||||||||||||||||||||||||||||||
Operating Expenses |
(87)
|
(92)
|
(97)
|
(108)
|
(118)
|
(130)
|
(141)
|
(142)
|
(142)
|
(139)
|
(137)
|
(143)
|
(141)
|
(138)
|
(133)
|
(129)
|
(137)
|
(145)
|
(157)
|
(163)
|
(168)
|
(184)
|
(191)
|
(197)
|
(189)
|
(182)
|
(183)
|
(187)
|
(191)
|
|
Selling, General & Administrative |
(23)
|
(25)
|
(26)
|
(29)
|
(31)
|
(36)
|
(39)
|
(42)
|
(44)
|
(44)
|
(43)
|
(43)
|
(43)
|
(41)
|
(41)
|
(43)
|
(46)
|
(50)
|
(54)
|
(56)
|
(57)
|
(60)
|
(61)
|
(63)
|
(61)
|
(65)
|
(71)
|
(70)
|
(64)
|
|
Research & Development |
(64)
|
(67)
|
(71)
|
(79)
|
(87)
|
(94)
|
(101)
|
(101)
|
(98)
|
(95)
|
(94)
|
(100)
|
(98)
|
(97)
|
(92)
|
(86)
|
(92)
|
(95)
|
(103)
|
(107)
|
(111)
|
(123)
|
(129)
|
(134)
|
(128)
|
(117)
|
(112)
|
(116)
|
(127)
|
|
Operating Income |
(73)
N/A
|
(78)
-7%
|
(79)
-1%
|
(66)
+17%
|
(81)
-23%
|
(87)
-8%
|
(92)
-6%
|
(80)
+13%
|
(82)
-3%
|
(88)
-7%
|
(94)
-8%
|
(142)
-50%
|
(140)
+1%
|
(136)
+3%
|
(130)
+4%
|
(126)
+3%
|
(133)
-6%
|
(142)
-6%
|
(151)
-6%
|
(157)
-4%
|
(162)
-3%
|
(174)
-7%
|
(179)
-3%
|
(180)
0%
|
(162)
+10%
|
(111)
+32%
|
(112)
-1%
|
(115)
-3%
|
(131)
-13%
|
|
Pre-Tax Income | ||||||||||||||||||||||||||||||
Interest Income Expense |
1
|
1
|
1
|
2
|
2
|
10
|
(5)
|
(8)
|
0
|
(9)
|
0
|
3
|
3
|
(2)
|
4
|
5
|
2
|
2
|
1
|
(1)
|
1
|
1
|
1
|
1
|
2
|
2
|
3
|
5
|
6
|
|
Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(2)
|
(2)
|
20
|
20
|
13
|
|
Total Other Income |
1
|
0
|
3
|
7
|
9
|
8
|
5
|
1
|
(13)
|
(5)
|
(5)
|
(5)
|
0
|
1
|
(0)
|
(2)
|
1
|
0
|
1
|
2
|
4
|
4
|
3
|
5
|
(1)
|
(1)
|
(0)
|
(2)
|
(1)
|
|
Pre-Tax Income |
(71)
N/A
|
(77)
-9%
|
(75)
+2%
|
(57)
+24%
|
(70)
-22%
|
(69)
+1%
|
(92)
-34%
|
(86)
+7%
|
(95)
-10%
|
(102)
-7%
|
(99)
+3%
|
(144)
-45%
|
(137)
+5%
|
(138)
-1%
|
(126)
+8%
|
(123)
+3%
|
(130)
-6%
|
(139)
-7%
|
(148)
-7%
|
(155)
-5%
|
(157)
-1%
|
(169)
-8%
|
(175)
-3%
|
(173)
+1%
|
(163)
+6%
|
(112)
+31%
|
(88)
+21%
|
(92)
-4%
|
(113)
-22%
|
|
Net Income | ||||||||||||||||||||||||||||||
Tax Provision |
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(3)
|
(2)
|
(3)
|
(3)
|
(1)
|
|
Income from Continuing Operations |
(72)
|
(78)
|
(76)
|
(58)
|
(70)
|
(69)
|
(93)
|
(87)
|
(96)
|
(102)
|
(99)
|
(144)
|
(137)
|
(138)
|
(127)
|
(123)
|
(130)
|
(140)
|
(149)
|
(156)
|
(158)
|
(171)
|
(176)
|
(175)
|
(165)
|
(114)
|
(91)
|
(95)
|
(114)
|
|
Net Income (Common) |
(72)
N/A
|
(78)
-9%
|
(76)
+2%
|
(58)
+23%
|
(70)
-20%
|
(69)
+1%
|
(93)
-34%
|
(87)
+7%
|
(96)
-10%
|
(102)
-7%
|
(99)
+3%
|
(144)
-45%
|
(137)
+5%
|
(138)
-1%
|
(127)
+8%
|
(123)
+3%
|
(130)
-6%
|
(140)
-7%
|
(149)
-7%
|
(156)
-5%
|
(158)
-1%
|
(171)
-8%
|
(176)
-3%
|
(175)
+1%
|
(165)
+5%
|
(114)
+31%
|
(91)
+20%
|
(95)
-5%
|
(114)
-20%
|
|
EPS (Diluted) |
-0.17
N/A
|
-0.18
-6%
|
-0.13
+28%
|
-0.1
+23%
|
-0.13
-30%
|
-0.13
N/A
|
-0.17
-31%
|
-0.13
+24%
|
-0.16
-23%
|
-0.17
-6%
|
-0.16
+6%
|
-0.23
-44%
|
-0.22
+4%
|
-0.18
+18%
|
-0.15
+17%
|
-0.13
+13%
|
-0.15
-15%
|
-0.16
-7%
|
-0.16
N/A
|
-0.17
-6%
|
-0.17
N/A
|
-0.18
-6%
|
-0.19
-6%
|
-0.18
+5%
|
-0.17
+6%
|
-0.12
+29%
|
-0.09
+25%
|
-0.08
+11%
|
-0.09
-13%
|